Priority Date: 03.05.12 (US 201261642261P)

PHARMACEUTICAL NANOPARTICLES SHOWING IMPROVED MUCOSAL TRANSPORT

  • Application ID: EP13723629
  • Status: EXAMINATION IN PROGRESS

Attorneys

no operation time available
8 offices
active in Legal Services
no operation time available
8 offices
active in Legal Services
Employment test 201 - 500 employees
Company dna regimbeau
operating since 1931
Headquarter in Paris and 8 offices
active in Legal Services and IP Consulting

Specialization

This EP application has the IPC class A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Urquhart-Dykes & Lord LLP and Cabinet Regimbeau are specialized in A61. Urquhart-Dykes & Lord LLP, Urquhart-Dykes & Lord LLP is specialised in A61 (MEDICAL OR VETERINARY SCIENCE; HYGIENE). Here you find a list of all patent agent firms which are specialized in this IPC class. For a similar patent, they might be a good choice.

Timeline

  • 03.05.2012 - Priority Date (US 201261642261P)
  • 07.11.2013 - Publication A1 (WO2013166436)
  • 11.03.2015 - Publication A1 (EP2844223)